MétaCan
Menu
Back to cohort
Record W4406200479 · doi:10.1002/alz.091813

Examining the relationship between angiopoietin‐2 and cognition in early Alzheimer’s disease

2024· article· en· W4406200479 on OpenAlexaffabout
Bing Xin Song, Erika L. Beroncal, Ana C. Andreazza, Damien Gallagher, Susan Marzolini, Mark Rapoport, Jocelyn Charles, Nathan Herrmann, Paul Oh, Alex Kiss, Walter Swardfager, Bradley J. MacIntosh, Tarek K. Rajji, Giovanni Marotta, Mehreen Siddiqui, Danielle Soares Rocha Vieira, Raphael W. Kusumo, Krista L. Lanctôt

Bibliographic record

VenueAlzheimer s & Dementia · 2024
Typearticle
Languageen
FieldMedicine
TopicLipid metabolism and disorders
Canadian institutionsCentre for Addiction and Mental HealthSunnybrook HospitalHealth Sciences CentreSunnybrook Health Science CentreToronto Rehabilitation InstituteUniversity of Toronto
Fundersnot available
KeywordsAngiopoietin 2CognitionDiseaseAlzheimer's diseasePsychologyMedicineNeuroscienceInternal medicine

Abstract

fetched live from OpenAlex

Abstract Background Angiopoietin‐2, which regulates endothelial permeability and angiogenesis functions, is emerging as a potential biomarker for early Alzheimer’s disease (AD). Elevated levels of cerebrospinal fluid angiopoietin‐2 concentrations have been found in early AD and may be associated with the breakdown of blood‐brain barrier that can contribute to cognitive decline. There is a lack of research on blood angiopoietin‐2 levels and cognition in early AD. Hence, we examined the association between serum angiopoietin‐2 and global cognition. Method Participants were diagnosed with mild cognitive impairment (MCI) due to AD or mild Alzheimer’s dementia using the Diagnostic and Statistical Manual of Mental Disorders 5 criteria for mild or major neurocognitive disorder. Serum angiopoietin‐2 concentrations (ng/mL) were measured and analyzed using enzyme‐linked immunosorbent assays. Global cognition was assessed by the Montreal Cognitive Assessment (MoCA). Linear regression analyses were used to assess the association between angiopoietin‐2 levels and cognition adjusting for covariates selected a priori: age and the presence of cardiovascular risk factors or disease (cardiovascular status). Angiopoietin‐2 levels were log‐transformed prior to analyses due to significant departure from normality in Shapiro‐Wilk tests. Result Of 30 participants [17 (57%) male, 21 (70%) MCI, 22 (73%) with cardiovascular risk factors or disease], the mean (SD) age was 74.8 (8.7), years of education was 16.3 (2.2), MoCA total score was 21.9 (3.4), and angiopoietin‐2 levels were 4.0 (3.6) ng/mL. Higher angiopoietin‐2 was associated with better cognition [F(3,26) = 6.7, p = .002, R2 = .44]. Controlling for age and cardiovascular status, one log angiopoietin‐2 unit was associated with a 4.2 (SE= 2.0) higher score in global cognition (p = .048, f2 = .10). Conclusion In this sample, higher serum angiopoietin‐2 concentrations were associated with better global cognition, controlling for age and cardiovascular status. This relationship supports the potential involvement of angiogenesis in cognitive functions and neurodegenerative diseases and suggests the need for further research to explore cardiovascular functions and cognition in early AD.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.004
Threshold uncertainty score0.009

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.083
GPT teacher head0.308
Teacher spread0.225 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2024
Admission routes2
Has abstractyes

Explore more

Same venueAlzheimer s & DementiaSame topicLipid metabolism and disordersFrench-language works237,207